At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

+66 98-828-1773

[email protected]

Category: Solid Organ Tumors and Cancers

Cancer staging is a critical process in oncology that helps determine the extent of cancer spread within the body. It is essential for guiding treatment decisions, predicting outcomes, and facilitating communication among healthcare providers. The most widely used staging system is the TNM system, which assesses the tumor size, lymph node involvement, and presence of metastasis.

12 Views 0 Comments April 16, 2025

Cancer Staging

Cancer staging is a critical process in oncology that helps determine the extent of cancer spread within the body. It is essential for guiding treatment decisions, predicting outcomes, and facilitating communication

17 Views 0 Comments April 16, 2025

Platinum-Based Chemotherapy (PBC)

Platinum-based chemotherapy (PBC) drugs, such as cisplatin, carboplatin, and oxaliplatin, are widely used in cancer treatment due to their ability to form DNA crosslinks that inhibit DNA replication and transcription, leading

Peptide receptor radionuclide therapy (PRRT) is a targeted cancer treatment that uses radiolabeled peptides to deliver therapeutic radiation directly to tumor cells. It is particularly effective for neuroendocrine tumors (NETs) that overexpress somatostatin receptors. Below is a detailed overview of PRRT, including its mechanisms, clinical applications, and potential side effects.

15 Views 0 Comments April 15, 2025

Peptide Receptor Radionuclide Therapy (PRRT)

Peptide receptor radionuclide therapy (PRRT) is a targeted cancer treatment that uses radiolabeled peptides to deliver therapeutic radiation directly to tumor cells. It is particularly effective for neuroendocrine tumors (NETs) that

Radiofrequency ablation (RFA), also known as fulguration, is a minimally invasive medical procedure that uses heat generated by high-frequency alternating current (350–500 kHz) to destroy targeted tissues. It is widely used in treating chronic pain, cardiac arrhythmias, and various tumors. Below is a detailed summary of RFA, including its mechanisms, applications, and potential risks.

21 Views 0 Comments April 14, 2025

Radiofrequency Ablation (RFA)

Radiofrequency ablation (RFA), also known as fulguration, is a minimally invasive medical procedure that uses heat generated by high-frequency alternating current (350–500 kHz) to destroy targeted tissues. It is widely used

Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking specific features of other NSCLC subtypes like adenocarcinoma or squamous cell carcinoma. Below is a detailed overview of LCC, including its symptoms, diagnosis, and treatment options.

13 Views 0 Comments April 12, 2025

Large Cell Carcinoma (LCC)

Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer (SCLC) but is often diagnosed at advanced stages due to its asymptomatic early course. Below is a detailed overview of NSCLC, including its subtypes, symptoms, risk factors, and treatment approaches.

21 Views 0 Comments April 12, 2025

Non-Small Cell Lung Cancer (NSCLC)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer

Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes, TKIs disrupt abnormal signaling in diseases like cancer and inflammatory disorders. Below is a detailed overview of TKIs, including their mechanisms, therapeutic uses, and challenges.

15 Views 0 Comments April 12, 2025

Tyrosine Kinase Inhibitors (TKI)

Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes,

23 Views 0 Comments April 11, 2025

Nanoparticle-Assisted Tumor Tracking (NATT)

Nanoparticle-Assisted Tumor Tracking (NATT) is an advanced approach in cancer research and treatment that uses nanoparticles to detect, monitor, and target tumors. This technology leverages the unique physicochemical properties of nanoparticles

Epidermal Growth Factor Receptor mutations (EGFRM) are genetic alterations in the EGFR gene that lead to abnormal cell growth and division, often resulting in cancer. These mutations are particularly significant in non-small cell lung cancer (NSCLC), where they serve as a biomarker for targeted therapies. Below is a detailed overview of EGFR mutations, including their types, clinical implications, and treatment options.

18 Views 0 Comments April 10, 2025

EGFR Mutations (EGFRM)

Epidermal Growth Factor Receptor mutations (EGFRM) are genetic alterations in the EGFR gene that lead to abnormal cell growth and division, often resulting in cancer. These mutations are particularly significant in

Adenocarcinoma is a type of cancer that originates in glandular epithelial cells, which are responsible for secreting mucus, digestive juices, or other fluids. It is one of the most common forms of cancer and can occur in various organs, including the breast, lung, colon, prostate, and pancreas. Below is a detailed overview of adenocarcinoma, including its types, clinical implications, and treatment options.

16 Views 0 Comments April 10, 2025

Adenocarcinoma (ADC)

Adenocarcinoma is a type of cancer that originates in glandular epithelial cells, which are responsible for secreting mucus, digestive juices, or other fluids. It is one of the most common forms

1
2

About Us

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

+66 98-828-1773

[email protected]

Copyright 2025 DrStemCellsThailand. All Rights Reserved by Anti-Aging and Regenerative Medicine Center of Thailand